Search
Conduit Pharmaceuticals Inc
CDTAdd to Watchlist
2.930USD
+0.250+9.33%
Close 07-31 16:00（ET）Quotes delayed by 15 min
13.84MMarket Cap
LossP/E TTM
CDT Financials
See Conduit Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Conduit Pharmaceuticals Inc Earnings Date
Latest Release
Jul 15, 2026
EPS / Forecast
-5.56/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-29.45K
52.19%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its current assets were 4.38M, with a year-on-year change of 61.29.
What are the total assets of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its total assets of Conduit Pharmaceuticals Inc were 5.65M, with a year-on-year change of 34.75.
What are the total liabilities of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Conduit Pharmaceuticals Inc were 12.82M, with a year-on-year change of 16.69.
What is the total equity of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its total equity of Conduit Pharmaceuticals Inc was -7.17M, with a year-on-year change of -5.55.
What is the net operating income of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Conduit Pharmaceuticals Inc was -36.76M, with a year-on-year change of -138.39.
What is the net investment of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its net investment of Conduit Pharmaceuticals Inc was -808.00K, with a year-on-year change of -1779.07.
What is the net financing of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its net financing of Conduit Pharmaceuticals Inc was 17.42M, with a year-on-year change of 187.16.
What is the Earnings Per Share (EPS) of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -29447.45, with a year-on-year change of 52.19.
What is the net income of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its net income was -39.22M, with a year-on-year change of -120.33.
What is the debt-to-asset ratio of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 11.68, with a year-on-year change of -93.23.
What is the Return on Assets (ROA) of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -796.99, with a year-on-year change of -155.57.
What is the operating profit of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -36.76M, with a year-on-year change of -138.39.